SCHEMBL17367341

SCHEMBL17367341

CCOc1cc[n+](-c2ncnc3[nH]cnc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTBK1 Q5TCY1 1/20 0.39
TTBK2 Q6IQ55 1/20 0.39
MAPT P10636 3/20 0.35
TSHR P16473 2/20 0.35
HTT P42858 2/20 0.35
NQO1 P15559 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TDP1 Q9NUW8 2/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
PRSS1 P07477 1/20 0.33
PRSS2 P07478 1/20 0.33
PRSS3 P35030 1/20 0.33
ALDH1A1 P00352 3/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TP53 P04637 1/20 0.33
XDH P47989 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17367351 0.89 SMN1; SMN2 (0.35) TTBK1TTBK2MAPTHTTSMN1; SMN2
SCHEMBL17367355 0.83 SMN1; SMN2 (0.39) TTBK1TTBK2MAPTTSHRHTT
SCHEMBL17367387 0.77 CA12 (0.33) NPC1
SCHEMBL17367347 0.77
Hydrochloric Acid SCHEMBL17364313 0.76 CA12 (0.35)
SCHEMBL1272493 0.76 DRD4 (0.30)
SCHEMBL17367353 0.74 PRKD3 (0.37) MAPTTDP1ALDH1A1KMT2A
SCHEMBL3388862 0.71 KDM4E (0.40) TTBK1TTBK2MAPTTSHRHTT
SCHEMBL4921526 0.70 SMN1; SMN2 (0.53) TTBK1TTBK2MAPTTSHRSMN1; SMN2
SCHEMBL17367361 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150376219-A1 Selective Preparations of Purine Nucleosides and Nucleotides: Reagents and Methods ZHONG MINGHONG (US) 2015-12-31 US disclosed
US-20150376219-A1 Selective Preparations of Purine Nucleosides and Nucleotides: Reagents and Methods ZHONG MINGHONG (US) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376219-A1 Selective Preparations of Purine Nucleosides and Nucleotides: Reagents and Methods PNP, ATIC, NT5C3B TTBK1 3304/4885TTBK2 2813/4885MAPT 4611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.